Evidence map›Paper›PMID 35087756›Full record

ArticleFrontiers in oncology2021

Tumor- and Osteoblast-Derived Periostin in Prostate Cancer bone Metastases.

Chuan-Yu Sun, Yuan-Yuan Mi, Sheng-Yang Ge, Qing-Feng Hu, Ke Xu, Yi-Jun Guo, Yi-Fan Tan, Yang Zhang, Fan Zhong, Guo-Wei Xia

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Chuan-Yu SunDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Yuan-Yuan MiDepartment of Urology, Affiliated Hospital of Jiangnan University, Wuxi, China.
Sheng-Yang GeDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Qing-Feng HuDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Ke XuDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Yi-Jun GuoDepartment of Urology, Jing'an District Central Hospital, Fudan University, Shanghai, China.
Yi-Fan TanDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Yang ZhangDepartment of Systems Biology for Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
Fan ZhongDepartment of Systems Biology for Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
Guo-Wei XiaDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Fudan University · CNHuashan Hospital · CNWuxi Fourth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exploring the biological function of periostin (POSTN) in prostate cancer (PCa) bone metastasis is of importance. It was observed that the expression of POSTN was high in PCa, especially highest in PCa metastasized to bone. In this study, we found that inhibiting POSTN in PCa cells could significantly alleviate PCa bone metastasis

Indexed as

bone metastasisintegrin receptorosteoblastperiostinprostate cancer

Identifiers

PMID35087756
PMCPMC8787093
OpenAlexW4206465886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.